Results
1 -
10 of
26
(Click
here to explore results)
- Recent advances in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. Xiu-Xiu Wang, Si-Yu Sun, Qing-Qing Dong, Xiao-Xiang Wu, Wei Tang, Ya-Qun Xing
, Med. Chem. Commun.
, 2019
, 10
, 1740
- Correction: IDO as a drug target for cancer immunotherapy: recent developments in IDO inhibitors discovery. Shan Qian, Man Zhang, Quanlong Chen, Yanying He, Wei Wang, Zhouyu Wang
, RSC Adv.
, 2016
, 6
, 61267
- Design, synthesis and evaluation of tryptophan analogues as tool compounds to study IDO1 activity. Nicholas J. Cundy, Roseanna K. Hare, Tina Tang, Andrew G. Leach, Thomas A. Jowitt, Omar Qureshi, John Gordon, Nicholas M. Barnes, Catherine A. Brady, Emma L. Raven, Richard S. Grainger, Sam Butterworth
, RSC Chem. Biol.
, 2021
, 2
, 1651
- Heme-containing enzymes and inhibitors for tryptophan metabolism. Daojing Yan, Ying-Wu Lin, Xiangshi Tan
, Metallomics
, 2017
, 9
, 1230
- IDO as a drug target for cancer immunotherapy: recent developments in IDO inhibitors discovery. Shan Qian, Man Zhang, Quanlong Chen, Yanying He, Wei Wang, Zhouyu Wang
, RSC Adv.
, 2016
, 6
, 7575
- Polypharmacology of epacadostat: a potent and selective inhibitor of the tumor associated carbonic anhydrases IX and XII. Andrea Angeli, Marta Ferraroni, Alessio Nocentini, Silvia Selleri, Paola Gratteri, Claudiu T. Supuran, Fabrizio Carta
, Chem. Commun.
, 2019
, 55
, 5720
- Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry. Alice Coletti, Francesco Antonio Greco, Daniela Dolciami, Emidio Camaioni, Roccaldo Sardella, Maria Teresa Pallotta, Claudia Volpi, Ciriana Orabona, Ursula Grohmann, Antonio Macchiarulo
, Med. Chem. Commun.
, 2017
, 8
, 1378
- Inhibition of immunosuppressive indoleamine 2,3-dioxygenase by targeting the heme and apo-form. Nirmalya Pradhan, Nasim Akhtar, Barnali Nath, Jorge Peña-García, Anjali Gupta, Horacio Pérez-Sánchez, Sachin Kumar, Debasis Manna
, Chem. Commun.
, 2021
, 57
, 395
- A polymeric IDO inhibitor based on poly(ethylene glycol)-b-poly(l-tyrosine-co-1-methyl-d-tryptophan) enables facile trident cancer immunotherapy. Yuanyuan Liu, Jiguo Xie, Xiaofei Zhao, Yueyue Zhang, Zhiyuan Zhong, Chao Deng
, Biomater. Sci.
, 2022
, 10
, 5731
- A dual-responsive doxorubicin–indoximod conjugate for programmed chemoimmunotherapy. Zhaoxuan Yang, Jiaqi Huang, Yaying Lin, Xiangjie Luo, Haojin Lin, Hongyu Lin, Jinhao Gao
, RSC Chem. Biol.
, 2022
, 3
, 853